Explore how pan-selective aptamers are targeting previously undruggable small GTPases, offering new hope for cancer and neurodegenerative disease treatments.
Exploring the revolutionary potential of catalytic nucleic acids as therapeutic agents in molecular medicine, targeting diseases from cancer to genetic disorders.
Explore how RNA interference (RNAi) is transforming medicine by silencing disease-causing genes with unprecedented precision.
Exploring the cutting-edge equipment needed to advance RNAi therapeutics research and development.